Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
- 9 July 1998
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (2), 69-75
- https://doi.org/10.1056/nejm199807093390202
Abstract
In patients with type 1 diabetes mellitus who do not have uremia and have not received a kidney transplant, pancreas transplantation does not ameliorate established lesions of diabetic nephropathy within five years after transplantation, but the effects of longer periods of normoglycemia are unknown. We studied kidney function and performed renal biopsies before pancreas transplantation and 5 and 10 years thereafter in eight patients with type 1 diabetes but without uremia who had mild to advanced lesions of diabetic nephropathy at the time of transplantation. The biopsy samples were analyzed morphometrically. All patients had persistently normal glycosylated hemoglobin values after transplantation. The median urinary albumin excretion rate was 103 mg per day before transplantation, 30 mg per day 5 years after transplantation, and 20 mg per day 10 years after transplantation (P=0.07 for the comparison of values at base line and at 5 years; P=0.11 for the comparison between base line and 10 years). The mean (±SD) creatinine clearance rate declined from 108±20 ml per minute per 1.73 m2 of body-surface area at base line to 74±16 ml per minute per 1.73 m2 at 5 years (P2 at 10 years (P<0.001). The thickness of the glomerular and tubular basement membranes was similar at 5 years (570±64 and 928±173 nm, respectively) and at base line (594±81 and 911±133 nm, respectively) but had decreased by 10 years (to 404±38 and 690±111 nm, respectively; P<0.001 and P=0.004 for the comparisons with the base-line values). The mesangial fractional volume (the proportion of the glomerulus occupied by the mesangium) increased from base line (0.33±0.07) to 5 years (0.39±0.10, P=0.02) but had decreased at 10 years (0.27±0.02, P=0.05 for the comparison with the base-line value and P=0.006 for the comparison with the value at 5 years), mostly because of a reduction in mesangial matrix. Pancreas transplantation can reverse the lesions of diabetic nephropathy, but reversal requires more than five years of normoglycemia.This publication has 28 references indexed in Scilit:
- Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipientsJAMA, 1994
- Cell and matrix components of the glomerular mesangium in type I diabetesDiabetes, 1992
- Mesangial expansion as a central mechanism for loss of kidney function in diabetic patientsDiabetes, 1989
- The Effects of Pancreas Transplantation on the Glomerular Structure of Renal Allografts in Patients with Insulin-Dependent DiabetesNew England Journal of Medicine, 1989
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- The long-term course of cyclosporine-associated chronic nephropathyKidney International, 1988
- Smooth Muscle-Mediated Connective Tissue Remodeling in Pulmonary HypertensionScience, 1987
- Studies of Kidney and Muscle Biopsy Specimens from Identical Twins Discordant for Type I Diabetes MellitusNew England Journal of Medicine, 1985
- Structural-functional relationships in diabetic nephropathy.Journal of Clinical Investigation, 1984
- The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patientsDiabetes, 1983